2-(Methacryloyloxy)ethyl 1,3-dioxo-1,3-dihydroisobenzofuran-5-carboxylate, 95.0%, 5g

(S)-2-Aminonon-8-enoic acid, 95.0%, 10g

tert-Butyl 3-(4-Methylbenzyl)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)azetidine-1-carboxylate>95.0%(GC)(T)250mg

3-Bromo-5-(trifluoromethoxy)pyridine, 98+%, 100mg

GC capillary column ROTI®Cap-1701, 30 m, 0.32 mm, 0.50 µm, 1 Piece(s)

1-Ethyladamantane, 95.0%, 25g

Ethyl 1-Piperidinepropionate>97.0%(GC)25mL

3-(Diethoxymethyl)-2-ethoxytetrahydro-2H-pyran, 95.0%, 2.5g

Methyl 6-hydroxyhexanoate, 95.0%, 2g

trans,trans-1,5-Bis(4-methoxyphenyl)-1,4-pentadien-3-one>98.0%(GC)200mg

SIVELESTAT, 95%, 5mg

Benzyl((3aR,4S,6R,6aS)-6-hydroxy-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)carbamate, 97%, 5mg

Double neck round bottom flasks, 250 ml, 14/23, 14/23, 1 Piece